HOME >> MEDICINE >> NEWS
Other highlights in the March 2 JNCI

ol of Public Health in Minneapolis, discusses two novel aspects of this study--comparing the offer of an explicit choice between screening tests to recommendations of a specific test and to the option of doing both tests, and comparing two methods of distributing the FOBT kits. He questions whether theoretical models of screening behavior would predict the surprising finding that subjects who were given a choice between screening methods did not have a higher screening participation rate than subjects who were not given a choice.

Contacts:

  • Article: Nereo Segnan, Centro Prevenzione Oncologica Regione Piemonte and Azienda Sanitaria Ospedaliera S Giovanni Battista, +390116333860, nereo.segnan@cpo.it
  • Editorial: Molly Portz, Media Relations, University of Minnesota, 612-625-2640, mportz@umn.edu

    Tamoxifen's Association With Endometrial Cancer Risk in Pre- and Postmenopausal Women Examined

    Tamoxifen use is associated with an increased risk of endometrial cancer. A new study has found that this risk is similar in pre- and postmenopausal women, increases with duration of use, and does not diminish through 5 years of follow-up after the treatment ends.

    Anthony J. Swerdlow, D.Sc., of the Institute of Cancer Research in Sutton, England, and colleagues conducted a casecontrol study in Britain of 813 patients who had endometrial cancer following breast cancer diagnosis and 1,067 control subjects who had breast cancer but not subsequent endometrial cancer.

    Overall, tamoxifen treatment was associated with 2.4 times the risk of endometrial cancer compared with no treatment. The risk increased with the duration of treatment and did not diminish in the 5 years following the end of treatment. The risk was similar in pre- and postmenopausal women. The authors write that, until further data are available, their results "suggest that the associated ris
    '"/>



  • Contact: Sarah L. Zielinski
    jncimedia@oupjournals.org
    301-841-1287
    Journal of the National Cancer Institute
    1-Mar-2005


    Page: 1 2 3 4

    Related medicine news :

    1. Other highlights in the March 16 JNCI
    2. Other highlights in the February 2 JNCI
    3. Other highlights in the January 19 JNCI
    4. Other highlights in the December 15 JNCI
    5. Other highlights in the December 1 JNCI
    6. Other highlights in the September 15 JNCI
    7. Other highlights in the April 21 JNCI
    8. Other highlights in the April 7 JNCI
    9. Other highlights in the January 7 issue of JNCI
    10. Other highlights in the December 3 issue of JNCI
    11. Other highlights in the November 19 issue of JNCI

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/27/2017)... ... February 27, 2017 , ... Texas ... week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. ... The company had 800 customers and 2,250 RCEs at the time of acquisition. ...
    (Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, ... awareness and concern over nerve agents and the deadly use of chemical weapons. Many ... system and how even small doses can be lethal. , Jay Jagannathan, M.D., of ...
    (Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing ... B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based ... of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales ...
    (Date:2/25/2017)... CA (PRWEB) , ... February 25, 2017 , ... FCPX ... ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have total control ... to easily refine their color range. With color spectrum tools users can visually see ...
    (Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
    Breaking Medicine News(10 mins):
    (Date:2/27/2017)... 27, 2017  A landmark study led ... MBBS, PhD, FRACS, of  Sydney Heart and Lung ... will be published in the February 28, 2017 issue ... College of Cardiology . According to the study, which involved 37,720 ... surgery technique (anOPCABG) reduced postoperative stroke by ...
    (Date:2/27/2017)... --  Royal Philips (NYSE: PHG ... technology, today announced 510(k) clearance from the U.S. ... ElastQ Imaging capability, further expanding the functionalities of ... enables simultaneous imaging of tissue and assessment of ... of various liver conditions. With ElastQ Imaging, clinicians ...
    (Date:2/27/2017)...   Vitasome ® Labs , Inc. has ... groundbreaking new liposome technology. Whereas vitamins lose on average ... per Physician,s Desk Reference , Vitasome , s ... waste and are scientifically formulated to: ... Improve bioavailability with a vastly higher absorption rate ...
    Breaking Medicine Technology:
    Cached News: